Track the LIG아큐버 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, LIG아큐버 has published 33 insider filings. Market capitalisation: €200bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 엘아이지. Every trade is free.
33
Insider Decl.
n/a
Thresholds
n/a
22 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate LIG아큐버 Buy (bullish), based on 1 analysts. Average price target: ₩50,000.
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,048 of 29,062 companies
22.3
score / 100
Value
18
Quality
26
FCF yld-5.1%
Earn yld-0.6%
EV/EBITDA44.7x
ROE·
Gross mgn24%
Net mgn-0.6%
Debt/EBITDA4.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
LIG아큐버 es una empresa del sector sanitario y farmacéutico, que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones farmacéuticas innovadoras.